Literature DB >> 30113379

Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

John W Devlin1,2, Yoanna Skrobik3,4, Céline Gélinas5, Dale M Needham6, Arjen J C Slooter7, Pratik P Pandharipande8, Paula L Watson9, Gerald L Weinhouse10, Mark E Nunnally11,12,13,14, Bram Rochwerg15,16, Michele C Balas17,18, Mark van den Boogaard19, Karen J Bosma20,21, Nathaniel E Brummel22,23, Gerald Chanques24,25, Linda Denehy26, Xavier Drouot27,28, Gilles L Fraser29, Jocelyn E Harris30, Aaron M Joffe31, Michelle E Kho30, John P Kress32, Julie A Lanphere33, Sharon McKinley34, Karin J Neufeld35, Margaret A Pisani36, Jean-Francois Payen37, Brenda T Pun23, Kathleen A Puntillo38, Richard R Riker29, Bryce R H Robinson39, Yahya Shehabi40, Paul M Szumita41, Chris Winkelman42, John E Centofanti43, Carrie Price44, Sina Nikayin45, Cheryl J Misak46, Pamela D Flood47, Ken Kiedrowski48, Waleed Alhazzani16,49.   

Abstract

OBJECTIVE: To update and expand the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the ICU.
DESIGN: Thirty-two international experts, four methodologists, and four critical illness survivors met virtually at least monthly. All section groups gathered face-to-face at annual Society of Critical Care Medicine congresses; virtual connections included those unable to attend. A formal conflict of interest policy was developed a priori and enforced throughout the process. Teleconferences and electronic discussions among subgroups and whole panel were part of the guidelines' development. A general content review was completed face-to-face by all panel members in January 2017.
METHODS: Content experts, methodologists, and ICU survivors were represented in each of the five sections of the guidelines: Pain, Agitation/sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption). Each section created Population, Intervention, Comparison, and Outcome, and nonactionable, descriptive questions based on perceived clinical relevance. The guideline group then voted their ranking, and patients prioritized their importance. For each Population, Intervention, Comparison, and Outcome question, sections searched the best available evidence, determined its quality, and formulated recommendations as "strong," "conditional," or "good" practice statements based on Grading of Recommendations Assessment, Development and Evaluation principles. In addition, evidence gaps and clinical caveats were explicitly identified.
RESULTS: The Pain, Agitation/Sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption) panel issued 37 recommendations (three strong and 34 conditional), two good practice statements, and 32 ungraded, nonactionable statements. Three questions from the patient-centered prioritized question list remained without recommendation.
CONCLUSIONS: We found substantial agreement among a large, interdisciplinary cohort of international experts regarding evidence supporting recommendations, and the remaining literature gaps in the assessment, prevention, and treatment of Pain, Agitation/sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption) in critically ill adults. Highlighting this evidence and the research needs will improve Pain, Agitation/sedation, Delirium, Immobility (mobilization/rehabilitation), and Sleep (disruption) management and provide the foundation for improved outcomes and science in this vulnerable population.

Entities:  

Mesh:

Year:  2018        PMID: 30113379     DOI: 10.1097/CCM.0000000000003299

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  472 in total

Review 1.  Evolving targets for sedation during mechanical ventilation.

Authors:  Steven D Pearson; Bhakti K Patel
Journal:  Curr Opin Crit Care       Date:  2020-02       Impact factor: 3.687

Review 2.  [Early mobilisation on the intensive care unit : What we know].

Authors:  Kristina Fuest; Stefan J Schaller
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-19       Impact factor: 0.840

3.  [Additive therapies : Intensive care studies from 2018-2019].

Authors:  M Dietrich; C J Reuß; C Beynon; A Hecker; C Jungk; D Michalski; C Nusshag; K Schmidt; M A Weigand; M Bernhard; T Brenner
Journal:  Anaesthesist       Date:  2020-01       Impact factor: 1.041

4.  In Reply.

Authors:  Norbert Zoremba; Mark Coburn
Journal:  Dtsch Arztebl Int       Date:  2019-05-24       Impact factor: 5.594

Review 5.  Acute Confusional States in Hospital.

Authors:  Norbert Zoremba; Mark Coburn
Journal:  Dtsch Arztebl Int       Date:  2019-02-15       Impact factor: 5.594

6.  Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Qingyu Zhang; Fuqiang Gao; Shuai Zhang; Wei Sun; Zirong Li
Journal:  Sleep Breath       Date:  2019-05-22       Impact factor: 2.816

Review 7.  Delirium in critically ill patients: current knowledge and future perspectives.

Authors:  M van den Boogaard; A J C Slooter
Journal:  BJA Educ       Date:  2019-10-28

8.  Simultaneous quantitative LC-MS method of ketamine, midazolam and their metabolites (dehydronorketamine, norketamine and 1hydroxymidazolam) for its application in patients on extracorporeal membrane oxygenation (ECMO) therapy.

Authors:  Ankit Rochani; Edwin Lam; Julian Tanjuakio; Hitoshi Hirose; Walter K Kraft; Gagan Kaushal
Journal:  J Pharm Biomed Anal       Date:  2019-10-24       Impact factor: 3.935

Review 9.  Family and healthcare staff's perception of delirium.

Authors:  Enrico Mossello; Flaminia Lucchini; Francesca Tesi; Laura Rasero
Journal:  Eur Geriatr Med       Date:  2020-01-01       Impact factor: 1.710

10.  Evaluation of Melatonin Practices for Delirium in Pediatric Critically Ill Patients.

Authors:  Thomas W Laudone; Shawna D Beck; Hubert J Lahr
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.